These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15279568)

  • 1. A molecular understanding of mast cell activation and the promise of anti-allergic therapeutics.
    Kovarova M; Rivera J
    Curr Med Chem; 2004 Aug; 11(15):2083-91. PubMed ID: 15279568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Picture of Mast Cell Activation: The Complex Regulatory Network of High-Affinity Receptor for Immunoglobulin E Signaling.
    Suzuki R
    Biol Pharm Bull; 2017; 40(11):1828-1832. PubMed ID: 29093329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk.
    Lee JH; Kim JW; Ko NY; Mun SH; Her E; Kim BK; Han JW; Lee HY; Beaven MA; Kim YM; Choi WS
    J Allergy Clin Immunol; 2008 May; 121(5):1225-31. PubMed ID: 18394691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
    Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
    J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
    Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
    Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the minimal region of peptide derived from ADP-ribosylation factor1 (ARF1) that inhibits IgE-mediated mast cell activation.
    Uchida R; Egawa T; Fujita Y; Furuta K; Taguchi H; Tanaka S; Nishida K
    Mol Immunol; 2019 Jan; 105():32-37. PubMed ID: 30472514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.
    Kraft S; Fleming T; Billingsley JM; Lin SY; Jouvin MH; Storz P; Kinet JP
    J Exp Med; 2005 Feb; 201(3):385-96. PubMed ID: 15684326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor.
    Furumoto Y; Gonzalez-Espinosa C; Gomez G; Kovarova M; Odom S; Parravicini V; Ryana JJ; Rivera J
    Immunol Res; 2004; 30(2):241-53. PubMed ID: 15477664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering.
    Suurmond J; Dorjée AL; Knol EF; Huizinga TW; Toes RE
    Clin Exp Allergy; 2015 Apr; 45(4):788-96. PubMed ID: 25665021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapters in the organization of mast cell signaling.
    Alvarez-Errico D; Lessmann E; Rivera J
    Immunol Rev; 2009 Nov; 232(1):195-217. PubMed ID: 19909365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IgE as a mast cell-stabilizing therapeutic agent.
    Chang TW; Shiung YY
    J Allergy Clin Immunol; 2006 Jun; 117(6):1203-12; quiz 1213. PubMed ID: 16750976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homoisoflavanone prevents mast cell activation and allergic responses by inhibition of Syk signaling pathway.
    Lee YS; Hur S; Kim TY
    Allergy; 2014 Apr; 69(4):453-62. PubMed ID: 24446972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
    Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
    Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Syk kinase inhibitor R112 by a human mast cell screen.
    Rossi AB; Herlaar E; Braselmann S; Huynh S; Taylor V; Frances R; Issakani SD; Argade A; Singh R; Payan DG; Masuda ES
    J Allergy Clin Immunol; 2006 Sep; 118(3):749-55. PubMed ID: 16950297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking the role of immunoglobulin E and its high-affinity receptor: new insights into allergy and beyond.
    Dema B; Suzuki R; Rivera J
    Int Arch Allergy Immunol; 2014; 164(4):271-9. PubMed ID: 25227903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syk-kinase inhibition prevents mast cell activation in nasal polyps.
    Patou J; Holtappels G; Affleck K; van Cauwenberge P; Bachert C
    Rhinology; 2011 Mar; 49(1):100-6. PubMed ID: 21468383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.